Edition:
United States

Entellus Medical Inc (ENTL.OQ)

ENTL.OQ on NASDAQ Stock Exchange Global Market

24.06USD
16 Feb 2018
Change (% chg)

$-0.04 (-0.17%)
Prev Close
$24.10
Open
$24.05
Day's High
$24.10
Day's Low
$24.05
Volume
21,216
Avg. Vol
63,849
52-wk High
$25.31
52-wk Low
$11.48

Chart for

About

Entellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems,... (more)

Overall

Beta: --
Market Cap(Mil.): $612.91
Shares Outstanding(Mil.): 25.47
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 34.52 17.27
EPS (TTM): -- -- --
ROI: -- 14.12 35.43
ROE: -- 16.75 17.10

BRIEF-Sand Grove Capital Reports 5.18 Pct Stake In Entellus Medical

* SAND GROVE CAPITAL MANAGEMENT LLP REPORTS 5.18 PERCENT STAKE IN ENTELLUS MEDICAL AS OF DEC 19 - SEC FILING‍​ Source text: (http://bit.ly/2zNjnCh) Further company coverage:

Dec 29 2017

BRIEF-Discovery Group I LLC Says Dissolves Stake In Entellus Medical As Of December 7

* DISCOVERY GROUP I LLC SAYS DISSOLVES STAKE IN ENTELLUS MEDICAL INC AS OF DECEMBER 7 - SEC FILING

Dec 08 2017

Stryker beefs up ENT business with $662 million Entellus buy

Medical device maker Stryker Corp said on Thursday it would buy Entellus Medical Inc for $662 million, adding heft to its ear, nose and throat (ENT) business.

Dec 07 2017

UPDATE 1-Stryker beefs up ENT business with $662 mln Entellus buy

Dec 7 Medical device maker Stryker Corp said on Thursday it would buy Entellus Medical Inc for $662 million, adding heft to its ear, nose and throat (ENT) business.

Dec 07 2017

BRIEF-Entellus Medical Says Deal May Require Co To Pay Stryker A Termination Fee Of $20.5 Mln

* ENTELLUS MEDICAL SAYS DEAL PROVIDES CO MAY BE REQUIRED TO PAY STRYKER TERMINATION FEE OF $20.5 MILLION UNDER CERTAIN CIRCUMSTANCES - SEC FILING Source text : (http://bit.ly/2iDEPDO) Further company coverage:

Dec 07 2017

Stryker to buy Entellus Medical for $662 mln

Dec 7 Medical device maker Stryker Corp said on Thursday it would buy medical technology company Entellus Medical Inc in a deal valued at about $662 million, adding heft to its ENT business.

Dec 07 2017

BRIEF-Stryker to buy Entellus Medical for $24.00/share in cash

* ENTELLUS MEDICAL ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR A PURCHASE PRICE OF $24.00 PER SHARE IN CASH

Dec 07 2017

BRIEF-Anthem Inc issues positive coverage decision for balloon sinus dilation

* Anthem Inc issues positive coverage decision for balloon sinus dilation

Nov 13 2017

BRIEF-Entellus Medical reports Q3 loss per share $0.13

* Entellus Medical Inc announces third quarter 2017 financial results

Nov 01 2017

BRIEF-Entellus Medical ‍announces data from its human study of Latera absorbable nasal implant from Spirox​

* ‍Announced data from its first-in-human study of Latera absorbable nasal implant from Spirox​

Oct 30 2017

Competitors

Earnings vs. Estimates